Life-Threatening Bleeding from Xarelto Prompts Lawsuit
A lawsuit has been filed on behalf of a patient who allegedly suffered fatal injuries because of life-threatening bleeding from Xarelto.
The plaintiff, who is representing the deceased individual, alleges that manufacturer Janssen Research and Development knew about severe bleeding risks but failed to warn the public and medical community about the dangers.
The dangerous side effects reported in the life-threatening bleeding from Xarelto lawsuit include personal and severe injuries that were lasting and permanent in nature. The plaintiff was allegedly given a prescription for Xarelto in December 2014 for treating atrial fibrillation. He reportedly used it from the beginning of December 2014 through March 12, 2015.
The lawsuit says the patient experienced a nosebleed on Feb. 1, 2015, a gastrointestinal bleed on March 12 and another bleeding event on March 11. He was admitted to the hospital on those events for treatments requiring blood transfusions as a result of using Xarelto.
The life-threatening bleeding from Xarelto lawsuit says that as a proximate indirect result of using this medication, the plaintiff suffered life-threatening and dangerous side effects that could have been prevented were he appropriately warned about the risks of the medication.
According to the life-threatening bleeding from Xarelto lawsuit filed on behalf of the deceased, the drug was believed to have been safe and effective for its indicated use..
He said he was never informed about the bleeding risks that ultimately led to his hospitalization.
The lawsuit alleges that the defendant concealed their awareness of the defects associated with from the medical community and public in general and the FDA.
The life-threatening bleeding from Xarelto lawsuit says that the defendants improperly and negligently failed to perform appropriate tests to identify the possible side effects associated with Xarelto.
Xarelto is prescribed to reduce the risk of systemic embolism and stroke in patients who have non-valvular atrial fibrillation to minimize the risk of recurrence of pulmonary embolism or DVT to treat deep vein thrombosis and for the prophylaxis of DVT for those patients going through knee or hip replacement surgery.
However, patients began to come forward with side effect concerns after serious bleeding events sent them to the hospital. If caught soon enough, doctors can work to minimize the impact of bleeding. If not addressed with transfusions and other responses from medical professionals, the patient may suffer fatal injuries from the loss of blood.
The Life-Threatening Bleeding From Xarelto Lawsuit is Case No. 2:18-cv-00932-EEF-MBN, in the U.S. District Court for the Eastern District of Louisiana.
If you or someone you know has been injured as a result of taking Xarelto, you may have grounds to pursue a lawsuit with the help of the attorneys at McDonald Worley.